Generic Name and Formulations:
Permethrin 5%; crm.
Various generic manufacturers
Indications for Permethrin:
Adults and Children:
<2 months: not recommended. ≥2 months: massage into skin from head to soles of feet. Remove 8–14hrs later by washing. Usually 1 treatment suffices; if living mites are present after 14 days, retreat. Infants: also treat scalp, temples and forehead. Wash or dryclean bedding and clothing appropriately.
Allergy to pyrethrins, pyrethroids, or chrysanthemums.
Avoid eyes. Pregnancy (Cat.B). Nursing mothers: not recommended.
Pruritus, burning, stinging, tingling, numbness, erythema, rash.
Formerly known under the brand names Acticin, Elimite.
Clinical Pain Advisor Articles
- Risks Associated With Co-Administration of Aspirin and Other NSAIDs
- Stages of Low Back Pain Have Specific Sets of Clinical Indicators
- FDA Approves Aimovig for Migraine Prevention
- First Non-Opioid Drug Approved for Managing Opioid Withdrawal Symptoms
- Pain Interference Associated With Depression, Pain Self-Efficacy in Chronic Musculoskeletal Pain
- Effect of Prescription Drug Monitoring Programs on Fatal, Nonfatal Drug Overdoses
- Standardized SCS Workflow May Effectively Alleviate Failed Back Surgery Syndrome-Related Pain
- Marijuana Legalization and Opioid Prescribing Rates
- Medical Marijuana Users More Likely to Use Prescription Drugs for Medical, Nonmedical Purposes
- Interbrain Coupling During Handholding Associated With Analgesia, Empathy
- Opioid-Related Adverse Drug Events Associated With Worse Patient, Cost Outcomes
- Education Plus Exercise, Single Corticosteroid Injection Effective in Long Term for Gluteal Tendinopathy
- Detox vs Medication-Assisted Treatment for Opioid Use Disorder in Pregnancy: Expert Roundtable
- Naloxone Training Beneficial for PA Students
- Supervised Injection Sites Hailed as the Latest Strategy to Fight the Opioid Crisis